GSK Stock Surges 50% in Volume, Ranks 385th as Jemperli Shows Promise in Cancer Treatment

Generado por agente de IAAinvest Market Brief
lunes, 28 de abril de 2025, 8:00 pm ET1 min de lectura
GSK--

On April 28, 2025, GSK's trading volume reached 2.19 billion, marking a 50.11% increase from the previous day, ranking 385th in the day's stock market. GSK's stock price rose by 1.68%.

GSK's checkpointCKPT-- blocker Jemperli has shown promising results in curing biomarker-driven rectal cancer. This development highlights the company's advancements in oncologyTOI-- research and could potentially drive investor interest in GSK's innovative treatments.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios